A Study on Intestinal Gas Symptoms to Evaluate the Effects of Gas Defense in Otherwise Healthy Adult

NACompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

September 30, 2008

Study Completion Date

September 30, 2008

Conditions
Abdominal PainAbdominal CrampsFlatulence
Interventions
DIETARY_SUPPLEMENT

BC-130 (Gas Defense)

"Product Dosing:~Take one capsule daily, at approximately the same time of day, without regard to food (may be taken with or without food)~Gas Defense Serving Size: 1 tablet Active Ingredients: B. Coagulans, Enzyme Blend (Cellulase - Trichoderma longibrachiatum, Cellulase - Aspergillus niger, Hemicellulase, Alpha Galactosidase, Invertase) Inactive Ingredients: vegetable capsule, Magnesium Stearate, Silicon Dioxide, Maltodextrin Contains: Wheat, Fish."

DIETARY_SUPPLEMENT

Placebo

"Product Dosing:~Take one capsule daily, at approximately the same time of day, without regard to food (may be taken with or without food)~Placebo - matched in size and color to the active product Inactive Ingredients: microcrystalline cellulose, FD\&C yellow #5 Lake, FD\&C blue #1 Lake, FD\&C red #46 Lake and vegetable capsule"

Trial Locations (2)

33143

Miami Research Associates, Miami

Unknown

Latin American Research, Santo Domingo

Sponsors
All Listed Sponsors
collaborator

Ganeden Biotech, Inc.

INDUSTRY

lead

Miami Research Associates

NETWORK

NCT00881322 - A Study on Intestinal Gas Symptoms to Evaluate the Effects of Gas Defense in Otherwise Healthy Adult | Biotech Hunter | Biotech Hunter